Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects

Lucy Kerr et al.

We have previously demonstrated that ivermectin used as prophylaxis for coronavirus disease 2019 (COVID- 19), irrespective of the regularity, in a strictly controlled citywide program in Southern Brazil (Itajaí, Brazil), was associated with reductions in COVID-19 infection, hospitalization, and mortality rates. In this study, our objective was to determine if the regular use of ivermectin impacted the level of protection from COVID- 19 and related outcomes, reinforcing the efficacy of ivermectin through the demonstration of a dose- response effect.

… This exploratory analysis of a prospective observational study involved a program that used ivermectin at a dose of 0.2 mg/kg/day for two consecutive days, every 15 days, for 150 days.

… Non-use of ivermectin was associated with a 12.5-fold increase in mortality rate and a seven-fold increased risk of dying from COVID-19 compared to the regular use of ivermectin. This dose-response efficacy reinforces the prophylactic effects of ivermectin against COVID-19.

Latest articles

William J. Walsh Each of us has innate biochemical factors which influence...
Joanna Moncrieff et al. The serotonin hypothesis of depression is still influential....
Raymond J. Pataracchia Biochemical syndromes of importance in mood and behaviour disorders...
Orthomolecular Medicine News Service Doctors report that mental health problems including depression,...
David R. Hawkins et al. Over the years a great many biochemical...
A Midwestern Doctor Many people believe the most significant issues facing the...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!